Results 101 to 110 of about 879 (214)

<i>In Vitro</i> and <i>In Vivo</i> Evaluation of the Antischistosomal Activity of Polygodial and 9-Deoxymuzigadial Isolated from <i>Drimys brasiliensis</i> Branches. [PDF]

Molecules
Umehara E, Cajas RA, Conceição GB, Antar GM, Andricopulo AD, Moraes J, Lago JHG.   +6 more
europepmc   +1 more source

Evaluation of serum-based real-time PCR to detect Schistosoma mansoni infection before and after treatment. [PDF]

Infect Dis Poverty, 2020
Fuss A, Mazigo HD, Mueller A.
europepmc   +1 more source

Non-covalent inhibitors of thioredoxin glutathione reductase with schistosomicidal activity in vivo. [PDF]

Nat Commun, 2023
Petukhova VZ, Aboagye SY, Ardini M, Lullo RP, Fata F, Byrne ME, Gabriele F, Martin LM, Harding LNM, Gone V, Dangi B, Lantvit DD, Nikolic D, Ippoliti R, Effantin G, Ling WL, Johnson JJ, Thatcher GRJ, Angelucci F, Williams DL, Petukhov PA.   +20 more
europepmc   +1 more source

Merck Open Global Health Library in vitro screening against Schistosoma mansoni identified two new substances with antischistosomal activities for further development. [PDF]

Parasit Vectors
Ueberall ME, Berchthold M, Häberli C, Lindemann S, Spangenberg T, Keiser J, Grevelding CG.   +6 more
europepmc   +1 more source

Pyrazoline derivatives as promising novel antischistosomal agents. [PDF]

Sci Rep, 2021
Morais CS, Mengarda AC, Miguel FB, Enes KB, Rodrigues VC, Espírito-Santo MCC, Siyadatpanah A, Wilairatana P, Couri MRC, de Moraes J.   +9 more
europepmc   +1 more source

Les schistosomiases en Afrique de l'Ouest [PDF]

, 1981
Boudin, Christian, Sellin, Bertrand
core  

In Silico Comparison of Bioactive Compounds Characterized from Azadirachta indica with an FDA-Approved Drug against Schistosomal Agents: New Insight into Schistosomiasis Treatment. [PDF]

Molecules
Oyinloye BE, Shamaki DE, Agbebi EA, Onikanni SA, Ubah CS, Aruleba RT, Dao TNP, Owolabi OV, Idowu OT, Mathenjwa-Goqo MS, Esan DT, Ajiboye BO, Omotuyi OI.   +12 more
europepmc   +1 more source

Plumbagin: A Promising In Vivo Antiparasitic Candidate against Schistosoma mansoni and In Silico Pharmacokinetic Properties (ADMET). [PDF]

Biomedicines, 2023
Silva LMN, França WWM, Santos VHB, Souza RAF, Silva AM, Diniz EGM, Aguiar TWA, Rocha JVR, Souza MAA, Nascimento WRC, Lima Neto RG, Cruz Filho IJ, Ximenes ECPA, Araújo HDA, Aires AL, Albuquerque MCPA.   +15 more
europepmc   +1 more source

Schistosomicidal effects of histone acetyltransferase inhibitors against Schistosoma japonicum juveniles and adult worms in vitro. [PDF]

PLoS Negl Trop Dis
Xu J, Wang JY, Huang P, Liu ZH, Wang YX, Zhang RZ, Ma HM, Zhou BY, Ni XY, Xiong CR, Xia CM.   +10 more
europepmc   +1 more source

Prevalence of urogenital and intestinal schistosomiasis among school children in South-west Nigeria. [PDF]

PLoS Negl Trop Dis, 2021
Ojo JA, Adedokun SA, Akindele AA, Olorunfemi AB, Otutu OA, Ojurongbe TA, Thomas BN, Velavan TP, Ojurongbe O.   +8 more
europepmc   +1 more source